PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Co-danthramer (Dantron/poloxamer 188)
Presentation Product Chemical substance Chapter Items dispensed
Co-danthramer 25mg/200mg/5ml oral suspension sugar free
0106020B0AAAAAA
Co-danthramer Co-danthramer (Dantron/poloxamer 188) Gastro-Intestinal System 201
Co-danthramer 75mg/1000mg/5ml oral suspension sugar free
0106020B0AAABAB
Co-danthramer Co-danthramer (Dantron/poloxamer 188) Gastro-Intestinal System 16
Ailax Forte oral suspension
0106020B0BDABAB
Ailax Co-danthramer (Dantron/poloxamer 188) Gastro-Intestinal System No data available
Ailax oral suspension
0106020B0BDAAAA
Ailax Co-danthramer (Dantron/poloxamer 188) Gastro-Intestinal System No data available
Co-danthramer 25mg/200mg capsules
0106020B0AAACAC
Co-danthramer Co-danthramer (Dantron/poloxamer 188) Gastro-Intestinal System No data available
Co-danthramer 25mg/200mg/5ml oral suspension
0106020B0AAAHAH
Co-danthramer Co-danthramer (Dantron/poloxamer 188) Gastro-Intestinal System No data available
Co-danthramer 37.5mg/500mg capsules
0106020B0AAAFAF
Co-danthramer Co-danthramer (Dantron/poloxamer 188) Gastro-Intestinal System No data available
Danlax oral suspension
0106020B0BEAAAH
Danlax Co-danthramer (Dantron/poloxamer 188) Gastro-Intestinal System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.